After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
The first official evaluation of the CanG reforms highlights early trends in market growth, youth use, health outcomes, and crime.
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning...
Representatives from five European countries, as well as the European Union Drug Agency (EUDA), met in Germany last week to discuss the regulation of cannabis for...
Via Business of Cannabis Mere hours after the results of the US election became clear, sending North American cannabis stocks into free fall, Germany’s ruling traffic...
The majority of doctors can now prescribe for reimbursement without prior approval of the health insurance companies.
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant...
94% reported they consume cannabis for at least one medical or health reason.
The proposed changes are set to have a major impact on the country’s already booming market.
